Blog - Announcements

Shawl Lobree Joins Vasomedical As President of VasoHealthcare

PLAINVIEW, NY / ACCESSWIRE / January 6, 2016 / Vasomedical, Inc. (“Vasomedical”) (VASO) today announced the appointment of Shawl Lobree as President of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, effective January 1, 2016. VasoHealthcare has since July 1, 2010 been the exclusive representative for the sale of select GE Healthcare Diagnostic Imaging products to specific market segments in the 48 contiguous states of the United States and the District of Columbia. GE Healthcare (“GEHC”) is the healthcare business of General Electric Company (NYSE:GE).

Mr. Lobree is succeeding Randy Hill, who has been President and CEO of VasoHealthcare since July 2012. Mr. Hill will remain a member of board of directors of Vasomedical as well as an active and strategic advisor to VasoHealthcare. With over 25 years of experience in the medical diagnostic imaging industry, Mr. Lobree has been involved in all aspects of imaging equipment business from product launch, marketing, sales, to services and support, at various capacities and with various responsibilities. He was Vice President, Global Sales and Marketing at Volpara Solutions Limited, a multinational company focused on optimization of multimodality breast imaging workflow until December 31, 2015. Prior to that, he spent over three years at Philips Healthcare as Vice President in charge of marketing strategy and operations for imaging systems and Vice President responsible for global marketing for diagnostic X-ray, as well as many more years in other major diagnostic imaging system manufacturers such as Hologic, Inc. and Siemens Medical Systems at different senior leadership positions in sales and marketing.

“Independent sales channels are an important part of overall sales strategy in the diagnostic imaging industry,” commented Mr. Lobree upon accepting the position. “I am very excited about the opportunity at Vasomedical and helping the company meet and exceed its growth plans. I truly look forward to working with Randy Hill and the exceptional team of Vaso sales professionals to further grow the business with our partner GE Healthcare.”

“We are fortunate to have another experienced industry leader joining the VasoHealthcare team,” Dr. Jun Ma, President and CEO of Vasomedical, stated in welcoming Mr. Lobree to Vasomedical. “Under the leadership of Randy Hill, VasoHealthcare has in the last several years established an exceptional track record and has grown into a major sales force in the domestic diagnostic imaging system market. I am confident that Shawl will continue to develop the business and expand our relationship with GEHC, bringing the operation to a new level.”

About Vasomedical

Vasomedical, Inc. is a diversified medical technology company with several distinct but related specialties: design, manufacture and sale of proprietary medical devices; professional sales services for diagnostic imaging products; and managed IT systems and services, including healthcare software solutions and network connectivity services.

Vasomedical operates through four wholly owned subsidiaries. Vaso Diagnostics, Inc. d.b.a. VasoHealthcare ( provides professional sales services and is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments in the USA. Vaso Technology, Inc. provides network and IT services through two business units: VasoHealthcare IT Corp., a national value added reseller of GE Healthcare IT’s Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support; and NetWolves Network Services LLC (, a managed network services provider with an extensive, proprietary service platform to a broad base of customers. Vasomedical Solutions, Inc. ( manages and coordinates the operations of design, manufacture and sales of EECP(R) Therapy Systems and other proprietary medical equipment. Vasomedical Global Corp. ( the Company’s China-based subsidiaries, including Biox Instruments Co. Ltd. and Life Enhancement Technology Limited. It is also the minority shareholder of VSK Medical Limited, a marketing and sales company for ECP/EECP products in the international market. Additional information is available on the Company’s website at

Link to Yahoo Finance:;_ylt=AwrC0CZpu5NWKGkA0kSTmYlQ;_ylu=X3oDMTEyNW9oMnUwBGNvbG8DYmYxBHBvcwMzBHZ0aWQDVklEMDNfMQRzZWMDc2M-